• Cy3 NHS Ester (Non-Sulfonated): Product Overview

  2026-10-04

  Cy3 NHS ester (non-sulfonated), SKU A8100, is a supplier-described orange fluorescent dye for conceptual amino-group labeling of proteins, peptides, and oligonucleotides. No matched paper evidence was provided, so performance claims remain unverified.

• Bile Acid Retention and Immune Escape in MASH-HCC

  2026-10-03

  A 2026 Cancer Letters study identifies a GPR120–FXR/ABCB11–bile acid–NLRC5 pathway that connects lipid-associated metabolic stress with defective MHC-I antigen presentation in MASH-HCC. Its genetic and pharmacological evidence suggests that reducing intracellular bile acid retention can improve tumor antigenicity and strengthen anti-PD-1 responses in mouse models, while clinical applicability remains un established.

• MOG (35-55) in EAE Research Workflows

  2026-10-02

  MOG (35-55) provides a sequence-defined trigger for experimental autoimmune encephalomyelitis, supporting controlled studies of neuroinflammation, demyelination, and immune-modulatory therapies. Its value increases when peptide handling, strain selection, and pathway-level assays are integrated into one reproducible workflow.

• PARP7 Inhibition Stabilizes STAT1/2 in EAE

  2026-10-01

  Xu et al. identify PARP7 as a suppressor of type I interferon signaling that ADP-ribosylates STAT1 and STAT2, promoting their ubiquitination and p62-dependent autophagic degradation. Inhibition of PARP7 restored interferon pathway activity and reduced experimental autoimmune encephalomyelitis in mice, linking a defined post-translational mechanism to disease-relevant neuroinflammation.

• Bifurcated Redox Sensing by TRPV1 and TRPA1

  2026-10-01

  The reference study shows that TRPV1 and TRPA1 distinguish singlet oxygen from hydrogen peroxide rather than responding to reactive oxygen species uniformly. By combining electrophysiology, calcium imaging, agonist-selective testing, and residue analysis, it identifies divergent channel responses with implications for mechanistic redox signaling studies.

• Bifurcated ROS Sensing by TRPV1 and TRPA1

  2026-09-30

  The reference study shows that TRPV1 and TRPA1 distinguish singlet oxygen from hydrogen peroxide through different channel-specific mechanisms. Its combination of electrophysiology, calcium imaging, agonist-selective testing, and residue analysis provides a framework for interpreting reactive oxygen species effects on ion-channel signaling.

• MK-8745: Selective Aurora A Inhibitor Workflows

  2026-09-30

  MK-8745 enables controlled studies of Aurora A–dependent mitotic arrest, tetraploidy, and apoptosis across cancer cell models. This workflow connects biochemical potency with practical experiments in p53 biology, non-Hodgkin lymphoma, retinoblastoma research, and tumor xenograft models while emphasizing formulation and interpretation controls.

• Rosiglitazone Workflow for PPARγ Metabolic Studies

  2026-09-29

  Build reproducible adipogenesis, insulin-response, and PPARG-variant rescue assays with Rosiglitazone, also known as Brl-49653. This guide connects practical dosing and controls with a recent FPLD3 study that used receptor activation to probe protein instability, mitochondrial dysfunction, and metabolic rescue.

• Carvacrol in Redox-Resolved Cell Assays

  2026-09-29

  Carvacrol is more than a TRPA1 agonist: it can help researchers separate reactive oxygen species sensing from downstream cell-fate responses. This guide translates recent channel biology into rigorous assay design for cell cycle research, apoptosis research, and mechanistic validation.

• KN-62: From CaMKII Mechanism to Translation

  2026-09-28

  KN-62 provides a focused pharmacological route to interrogate CaMKII-linked calcium signaling, secretion, metabolism, and cell-cycle phenotypes. This article connects that tool to emerging evidence that proteolytic signaling sustains social memory, while defining the controls translational researchers need before extending findings across biological domains.

• MOG (35-55): EAE Workflow and Assay Insights

  2026-09-28

  Use MOG (35-55) to establish a defined antigen challenge for experimental autoimmune encephalomyelitis (EAE) and investigate neuroinflammation in a multiple sclerosis research setting. This guide connects peptide handling and study design with recent evidence that PARP7 inhibition can alter type I interferon signaling and EAE outcomes.

• miR-18a–ALOXE3 Signaling in Glioblastoma

  2026-09-27

  The study identifies a tumor-suppressive role for ALOXE3 in glioblastoma: its loss reduces ferroptotic sensitivity and promotes migration through lipid signaling. It places miR-18a upstream of ALOXE3, outlining a molecular axis that connects microRNA regulation, cell death, and tumor behavior while leaving important questions about clinical translation unresolved.

• Autophagy, Lipid Breakdown, and Salmon Lipotoxicity

  2026-09-26

  In Atlantic salmon SHK-1 cells, rapamycin-induced autophagy was associated with lipid-droplet breakdown and reduced lipotoxic stress, while lipidomics and proteomics revealed changes in lipid storage and lipogenic proteins. The study provides a fish-cell model for investigating lipophagy and highlights why lipid composition and autophagic activity should be assessed together rather than treating total lipid abundance as the sole outcome.

• Optimizing hiPSC-Derived Functional Platelet Production

  2026-09-25

  Yue and colleagues developed an optimized differentiation scheme that shortens hiPSC-to-platelet production to 19 days while increasing reported output and lowering estimated costs. Their findings emphasize the combined effects of embryoid-body input, human platelet lysate, small-molecule substitutions, and megakaryocyte maturation on producing platelets with measurable in-vitro clot activity.

• Rosiglitazone A4304: Reliable Metabolic Assay Design

  2026-09-25

  A scenario-driven guide to using Rosiglitazone (SKU A4304) in metabolic, viability, and cytotoxicity workflows. It covers PPARγ biology, stock preparation, assay interpretation, and evidence-based product selection without treating metabolic readouts as direct measures of cell number.

8366 records 1/558 page Next 12345 下5页 Last page